MoonLake Immunotherapeutics
MLTX
MLTX
45 hedge funds and large institutions have $113M invested in MoonLake Immunotherapeutics in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
Holders
45
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$11.8M | |
| 2 | +$5.27M | |
| 3 | +$4.35M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$3.68M |
| 5 |
AWG
Alpha Wave Global
New York
|
+$3.04M |
Top Sellers
| 1 | -$7.39M | |
| 2 | -$6.96M | |
| 3 | -$4.94M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.78M |
| 5 |
FC
Finepoint Capital
Boston,
Massachusetts
|
-$3.77M |